Plasmid-Determined AmpC-Type β-Lactamases

By A. Philippon, G. Arlet, G. Jacoby. Antimicrobial Agents and Chemotherapy, 2002

789 citations recorded by the source corpus.

Subfields: Molecular Medicine, Pharmacology, Pollution

View Paper: https://www.semanticscholar.org/paper/1ed95813695d432e5d4d32867d10780cfeb35ba7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Medicine

1. J. Pitout
2. 古谷 良輔
3. 山口 和将
4. G. Peirano
5. D. Livermore
6. Amy Mathers

In Pharmacology

1. J. Pitout
2. D. Livermore

In Pollution

1. J. Pitout

Citations in the corpus

• Bacterial resistance: origins, epidemiology, and impact. (2003, background): “coli are chromosomal escapes from Citrobacter freundii, Hafnia alvei, Morganella morganii, and Enterobacter cloacae [42, 43], and several CTX-M cefotaximases are chromosomal escapes from Kluyvera spp.”
• The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae (2015, background): “Since high risk clones and epidemic plasmids do not play important roles in the global dissemination of AmpC enzymes, we refer the readers to some excellent review articles on this topic (22-24).”
• Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. (2008, background): “pneumoniae do not produce an ESBL, but rather a plasmid-mediated AmpC-type enzyme (52).”